Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory Non-Coding RNAs during Porcine Viral Infections: Potential Targets for Antiviral Therapy. | Viruses | 2024 | 38257818 | PubTator, text mining | PubMed |
| Favipiravir Analogues as Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase, Combined Quantum Chemical Modeling, Quantitative Structure-Property Relationship, and Molecular Docking Study. | Molecules | 2024 | 38257352 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus: Etiology, Epidemiology, Antigenicity, and Control Strategies in China. | Animals (Basel) | 2024 | 38254462 | PubTator, text mining | PubMed |
| MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning. | Cell Biosci | 2024 | 38245780 | PubTator, text mining | PubMed |
| Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors. | Acta Pharm Sin B | 2024 | 38239241 | PubTator, text mining | PubMed |
| Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2. | Commun Chem | 2024 | 38238420 | PubTator, text mining | PubMed |
RETRACTED: Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder. | PLoS One | 2024 | 38227609 | PubTator, text mining | PubMed |
| ZNF283, a Krüppel-associated box zinc finger protein, inhibits RNA synthesis of porcine reproductive and respiratory syndrome virus by interacting with Nsp9 and Nsp10. | Vet Res | 2024 | 38225617 | PubTator, text mining | PubMed |
| Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis. | J Enzyme Inhib Med Chem | 2024 | 38221792 | PubTator, text mining | PubMed |
| HCC-Related lncRNAs: Roles and Mechanisms. | Int J Mol Sci | 2024 | 38203767 | PubTator, text mining | PubMed |
| Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review. | Clin Pharmacol | 2024 | 38197085 | PubTator, text mining | PubMed |
| Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design. | Nat Commun | 2024 | 38195625 | PubTator, text mining | PubMed |
| Natural products targeting the MAPK-signaling pathway in cancer: overview. | J Cancer Res Clin Oncol | 2024 | 38193944 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir. | Clin Pharmacokinet | 2024 | 38177893 | PubTator, text mining | PubMed |
| Expression of NELL2/NICOL-ROS1 lumicrine signaling-related molecules in the human male reproductive tract. | Reprod Biol Endocrinol | 2024 | 38169386 | PubTator, text mining | PubMed |
| TEP SNORD12B, SNORA63, and SNORD14E as novel biomarkers for hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC). | Cancer Cell Int | 2024 | 38167096 | PubTator, text mining | PubMed |
| Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology. | IJID Reg | 2024 | 38149263 | PubTator, text mining | PubMed |
| Clinical development of antivirals against SARS-CoV-2 and its variants. | Curr Res Microb Sci | 2024 | 38149085 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2. | Steroids | 2024 | 38101718 | PubTator, text mining | PubMed |
| The SDS22:PP1:I3 complex: SDS22 binding to PP1 loosens the active site metal to prime metal exchange. | J Biol Chem | 2024 | 38042495 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=5